AstraZeneca buys into protein drugs for $200M+ - DBT - Delaware Business Times

Retrieved on: 2022-01-07 18:09:07

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca buys into protein drugs for $200M+ - DBT - Delaware Business Times. View article details on hiswai:

Excerpt

AstraZeneca has signed two separate drug development and licensing deals in the past month to treat a rare protein disease.

Article found on: delawarebusinesstimes.com